Myocardial Telomere Recapping Study for Dilated Cardiomyopathy

EARLY_PHASE1Active, not recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 30, 2023

Primary Completion Date

July 30, 2025

Study Completion Date

December 30, 2025

Conditions

Heart FailureDilated Cardiomyopathy

Interventions

BIOLOGICAL

JV001

JV001 (AAV9/modTERT) will be delivered by a percutaneous method in the catheter laboratory. Dose: 2×10\^11vg/kg，or 6×10\^11vg/kg.

Trial Locations (1)

Shanghai East Hospital, Shanghai

All Listed Sponsors

collaborator

Shanghai Juvensis Therapeutics Biotechnology Company Limited

UNKNOWN

lead

Shanghai East Hospital

OTHER

NCT05837143 - Myocardial Telomere Recapping Study for Dilated Cardiomyopathy | Biotech Hunter | Biotech Hunter